- The Commercialization of Human Stem Cells: Ethical and Policy Issues. [REVIEW]David B. Resnik - 2002 - Health Care Analysis 10 (2):127-154.details
|
|
Reviews in Health Law: Patenting Technology Instead of Identity.David B. Resnik & Kelly McPherson Jolley - 2004 - Journal of Law, Medicine and Ethics 32 (3):524-527.details
|
|
Reviews in Health Law: Patenting Technology Instead of Identity.David B. Resnik & Kelly McPherson Jolley - 2004 - Journal of Law, Medicine and Ethics 32 (3):524-527.details
|
|
Patents on Human-Animal Chimeras and Threats to Human Dignity.David B. Resnik - 2003 - American Journal of Bioethics 3 (3):35-36.details
|
|
Embryonic Stem Cell Patents and Human Dignity.David B. Resnik - 2007 - Health Care Analysis 15 (3):211-222.details
|
|
Biotechnologies and Human Dignity.Joseph Masciulli & William Sweet - 2011 - Bulletin of Science, Technology and Society 31 (1):6-16.details
|
|
Ethics of Buying DNA.Julian J. Koplin, Jack Skeggs & Christopher Gyngell - 2022 - Journal of Bioethical Inquiry 19 (3):395-406.details
|
|
Patent Ethics: The Misalignment of Views Between the Patent System and the Wider Society.Ellen-Marie Forsberg, Anders Braarud Hanssen, Hanne Marie Nielsen & Ingrid Olesen - 2018 - Science and Engineering Ethics 24 (5):1551-1576.details
|
|
Seven Risks Emerging From Life Patents and Corporate Science.Merryn Ekberg - 2005 - Bulletin of Science, Technology and Society 25 (6):475-483.details
|
|
The Case for Caution? Being protective of Human Dignity in the Face of Corporate Forces Taking Title to Our DNA.Barry Brown - 2001 - Journal of Law, Medicine and Ethics 29 (1):166-169.details
|
|
The Case for Caution ? Being protective of Human Dignity in the Face of Corporate Forces Taking Title to Our DNA.Barry Brown - 2001 - Journal of Law, Medicine and Ethics 29 (2):166-169.details
|
|
The Case for Caution — Being Protective of Human Dignity in the Face of Corporate Forces Taking Title to Our DNA.Barry Brown - 2001 - Journal of Law, Medicine and Ethics 29 (2):166-169.details
|
|